On Identifying Effective and Superior Drug Combinations via Holm's Procedure Based on the Min Tests

In this paper I consider a problem of identifying all effective and superior drug combinations. I formulate this problem in terms of a family of hypotheses and propose a two-stage method to solve it. The first stage uses individual p-values obtained via the Min tests, whereas Holm's approach is employed in the second stage to draw simultaneous inferences. This procedure is shown to control the family-wise error rate in a strong sense. The performance of the procedure is studied by simulation for different parameter settings. The conclusions of the simulation study are stated in terms of the power, family-wise error rate and lack of power.

[1]  Wei Liu,et al.  Multiple Tests of a Non‐Hierarchical Finite Family of Hypotheses , 1996 .

[2]  Sample Size Determination for Testing Whether an Identified Treatment Is Best , 2000, Biometrics.

[3]  G Y Chi,et al.  Testing for the existence of a desirable dose combination. , 1993, Biometrics.

[4]  G. Hommel.  A stagewise rejective multiple test procedure based on a modified Bonferroni test , 1988 .

[5]  P. Westfall,et al.  Gatekeeping strategies for clinical trials that do not require all primary effects to be significant , 2003, Statistics in medicine.

[6]  S. Snapinn,et al.  Evaluating the efficacy of a combination therapy. , 1987, Statistics in medicine.

[7]  Charles W. Dunnett,et al.  Stepwise multiple test procedures with biometric applications , 1999 .

[8]  R. Simes,et al.  An improved Bonferroni procedure for multiple tests of significance , 1986 .

[9]  Charles W. Dunnett,et al.  A Step-Up Multiple Test Procedure , 1992 .

[10]  Carl J. Huberty,et al.  Multiple Testing and Statistical Power With Modified Bonferroni Procedures , 1997 .

[11]  B. Holland,et al.  An Improved Sequentially Rejective Bonferroni Test Procedure , 1987 .

[12]  H. Keselman,et al.  Multiple Comparison Procedures , 2005 .

[13]  E. Laska,et al.  Testing whether an identified treatment is best. , 1989, Biometrics.

[14]  S James,et al.  Approximate multinormal probabilities applied to correlated multiple endpoints in clinical trials. , 1991, Statistics in medicine.

[15]  Xin Wang,et al.  Stepwise Gatekeeping Procedures in Clinical Trial Applications , 2006, Biometrical journal. Biometrische Zeitschrift.

[16]  E. Laska,et al.  Testing Hypotheses about an Identified Treatment when there are Multiple Endpoints , 1992 .

[17]  W. Lehmacher,et al.  Closure Procedures for Monotone Bi‐Factorial Dose–Response Designs , 2005, Biometrics.

[18]  Xin Wang,et al.  Tree‐structured gatekeeping tests in clinical trials with hierarchically ordered multiple objectives , 2007, Statistics in medicine.

[19]  H M Hung.  Evaluation of a combination drug with multiple doses in unbalanced factorial design clinical trials. , 2000, Statistics in medicine.

[20]  Allan R Sampson,et al.  On Identifying Minimum Efficacious Doses in Combination Drug Trials , 2009, Statistics in biopharmaceutical research.

[21]  Y. Hochberg.  A sharper Bonferroni procedure for multiple tests of significance , 1988 .

[22]  P. Westfall,et al.  Optimally weighted, fixed sequence and gatekeeper multiple testing procedures , 2001 .

[23]  S. S. Young,et al.  Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment , 1993 .

[24]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .

[25]  K. Pearson,et al.  Statistical Tests , 1935, Nature.

[26]  G. Hommel,et al.  Powerful short‐cuts for multiple testing procedures with special reference to gatekeeping strategies , 2007, Statistics in medicine.

[27]  L. Hothorn,et al.  Testing strategies in multi-dose experiments including active control. , 1998, Statistics in medicine.